A detailed history of Citizens National Bank Trust Department transactions in Eli Lilly & CO stock. As of the latest transaction made, Citizens National Bank Trust Department holds 15 shares of LLY stock, worth $11,935. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15
Previous 15 -0.0%
Holding current value
$11,935
Previous $13,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$724.87 - $909.04 $3,624 - $4,545
-5 Reduced 25.0%
15 $13,000
Q1 2024

May 03, 2024

SELL
$592.2 - $792.28 $11,844 - $15,845
-20 Reduced 50.0%
20 $15,000
Q3 2023

Oct 25, 2023

SELL
$434.7 - $599.3 $4,347 - $5,993
-10 Reduced 20.0%
40 $21,000
Q2 2023

Jul 24, 2023

BUY
$350.74 - $468.98 $17,537 - $23,449
50 New
50 $23,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Citizens National Bank Trust Department Portfolio

Follow Citizens National Bank Trust Department and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens National Bank Trust Department, based on Form 13F filings with the SEC.

News

Stay updated on Citizens National Bank Trust Department with notifications on news.